Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/57865

TitleAcetyl Cholinesterase Inhibitors and Cell-Derived Peripheral Inflammatory Cytokines in Early Stages of Alzheimer's Disease
Author(s)Kokras, Nikolaos
Stamouli, Evangelia
Sotiropoulos, I.
Katirtzoglou, Everina A.
Siarkos, Kostas T.
Dalagiorgou, Georgia
Alexandraki, Krystallenia I.
Coulocheri, Stavroula
Piperi, Christina
Politis, Antonios M.
KeywordsAged
Alzheimer Disease
Cholinesterase Inhibitors
Cytokines
Donepezil
Female
Follow-Up Studies
Humans
Indans
Inflammation
Male
Middle Aged
Piperidines
Alzheimer's disease
anticholinesterase inhibitors
Issue dateApr-2018
PublisherWolters Kluwer Health
JournalJournal of Clinical Psychopharmacology
CitationKokras, N., Stamouli, E., Sotiropoulos, I., Katirtzoglou, E. A., Siarkos, K. T., Dalagiorgou, G., ... & Politis, A. M. (2018). Acetyl Cholinesterase Inhibitors and Cell-Derived Peripheral Inflammatory Cytokines in Early Stages of Alzheimer's Disease. Journal of clinical psychopharmacology, 38(2), 138-143
Abstract(s)Clinical and preclinical studies firmly support the involvement of the inflammation in the pathogenesis of Alzheimer's disease (AD). Despite acetylcholinesterase inhibitors (AChEI) being widely used in AD patients, there is no conclusive evidence about their impact on the inflammatory response.
TypeArticle
URIhttp://hdl.handle.net/1822/57865
DOI10.1097/JCP.0000000000000840
ISSN0271-0749
e-ISSN1533-712X
Publisher versionhttps://journals.lww.com/psychopharmacology/Abstract/2018/04000/Acetyl_Cholinesterase_Inhibitors_and_Cell_Derived.9.aspx
Peer-Reviewedyes
AccessOpen access
Appears in Collections:ICVS - Artigos em Revistas Internacionais com Referee


Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID